Sandoz’ Saynor Insists US Biosimilars Market Is Stepping Up
US And Europe Were Once ‘Venus And Mars’ – But Promising Signs Emerging
Sandoz CEO Richard Saynor says he sees promising signs from the US biosimilars market that suggest it is beginning to meet its potential, albeit remaining many years behind the European market.
